GlassScriptPhysician profile
Elizabeth G Moy
NPI 1447327572
$3,875.06
in general payments reported to CMS, 2019-2025
32 companies · $773 in 2025
The $773 reported for 2025 was more than what 88% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $29.44 · 2021: $318 · 2022: $695 · 2023: $781 · 2024: $1,024 · 2025: $773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,404 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,403.98 |
| Education | $173.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $611.37 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $395.98 | 2022-2025 | Acessa Provu System, Aptima, Myosure Tissue Removal Device |
| Abbvie INC. | $369.74 | 2019-2023 | |
| Biogen, INC. | $271.68 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $228.71 | 2019-2022 | |
| Amgen INC. | $200.23 | 2023-2025 | Evenity, Prolia, Prolia |
| Organon LLC | $175.06 | 2021-2025 | Nexplanon |
| Ethicon US, LLC | $156.65 | 2021-2023 | Stratafix, Harmonic, Dermabond |
| Millicent US INC | $142.48 | 2024-2025 | Intrarosa, Femring |
| Avion Pharmaceuticals | $139.71 | 2019-2022 | |
| Myriad Women'S Health, INC. | $136.88 | 2023 | |
| Mayne Pharma Commercial LLC | $131.05 | 2021-2025 | |
| Evofem Biosciences, INC. | $119.27 | 2021-2024 | Phexxi |
| Coopersurgical, INC. | $79.98 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Shield Therapeutics INC | $76.30 | 2023-2025 | Accrufer |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $66.21 | 2024-2025 | |
| Minerva Surgical, INC | $63.01 | 2023-2024 | |
| Sage Therapeutics, LLC | $53.66 | 2022-2024 | |
| Exeltis, USA INC. | $49.98 | 2025 | Slynd |
| Scynexis, INC. | $48.69 | 2022 | |
| Ascend Therapeutics US, LLC | $44.26 | 2023-2024 | |
| Lilly USA, LLC | $43.66 | 2024 | Zepbound, Jardiance |
| Myovant Sciences INC. | $42.62 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.69 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $32.84 | 2024 | |
| Sanofi Pasteur INC. | $31.27 | 2024 | |
| Merck Sharp & Dohme LLC | $30.71 | 2019 | |
| Exact Sciences Corporation | $23.62 | 2023 | Cologuard Collection Kit |
| Meditrina | $20.58 | 2025 | |
| Vertical Pharmaceuticals, LLC | $18.81 | 2019 | |
| Aspira Women'S Health INC | $17.33 | 2022 | |
| Agile Therapeutics, INC. | $17.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Moy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.